Galectin Therapeutics Operating Expenses | GALT

Annual Operating Expenses Galectin Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
20.1 M	42.4 M	38.1 M	38.4 M	30.2 M	23.4 M	13.4 M	13.6 M	16.2 M	21.5 M	20.1 M	15.4 M	12.1 M	9.9 M	10.4 M	4.88 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
42.4 M	4.88 M	20.6 M

Quarterly Operating Expenses Galectin Therapeutics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.08 M	4.2 M	4.62 M	7.9 M	-	9.07 M	11.3 M	9.65 M	-	9.17 M	9 M	10.3 M	-	8.12 M	9.66 M	9.94 M	-	8.24 M	8.19 M	6.32 M	-	5.93 M	6.1 M	3.58 M	-	2.86 M	3.02 M	2.37 M	-	2.68 M	3.76 M	4.18 M	-	4.41 M	4.51 M	4.95 M	-	4.54 M	5.53 M	6.81 M	-	5.9 M	4.66 M	4.84 M	-	3.48 M	3.38 M	4.84 M	-	3.54 M	2.55 M	3.21 M	-	2.9 M	2.67 M	1.95 M	-	2.03 M	2.99 M	2.01 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
11.3 M	1.95 M	5.35 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Windtree Therapeutics WINT	26.1 M	-	-	$ 26.8 M	USA
Trean Insurance Group TIG	-121 K	-	-	$ 316 M	USA
SQZ Biotechnologies Company SQZ	102 M	-	57.95 %	$ 12.8 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Applied Therapeutics APLT	105 M	-	-	$ 8.42 M	USA
ESSA Pharma EPIX	34.4 M	-	-	$ 8.86 M	Canada
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
Clearside Biomedical CLSD	33.1 M	-	-	$ 25.3 M	USA
MEI Pharma MEIP	46.9 M	-	10.43 %	$ 20.5 M	USA
Palatin Technologies PTN	21.9 M	-	-	$ 13 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Lyra Therapeutics LYRA	31.4 M	-	-	$ 24.9 M	USA
Завод ДИОД DIOD	249 M	-	-	-	Russia
Фармсинтез LIFE	201 M	-	-	-	Russia
Ionis Pharmaceuticals IONS	752 M	$ 43.5	0.62 %	$ 6.96 B	USA
Agios Pharmaceuticals AGIO	543 M	$ 31.25	0.88 %	$ 1.81 B	USA
Foghorn Therapeutics FHTX	117 M	$ 2.0	0.74 %	$ 126 M	USA
Inhibikase Therapeutics IKT	3.52 M	$ 2.0	0.5 %	$ 197 M	USA
Kamada Ltd. KMDA	69 K	$ 8.0	1.34 %	$ 461 M	Israel
Intellia Therapeutics NTLA	121 M	$ 12.75	4.0 %	$ 1.38 B	USA
Ultragenyx Pharmaceutical RARE	595 M	$ 14.5	3.19 %	$ 1.43 B	USA
Viridian Therapeutics VRDN	434 M	$ 19.0	2.16 %	$ 1.93 B	USA
AbbVie ABBV	12.8 B	$ 265.76	1.12 %	$ 470 B	USA
AbCellera Biologics ABCL	292 M	$ 13.78	0.29 %	$ 4.12 B	Canada
Abeona Therapeutics ABEO	64.2 M	$ 5.11	1.59 %	$ 271 M	USA
Arbutus Biopharma Corporation ABUS	52.2 M	$ 4.67	4.94 %	$ 895 M	Canada
ACADIA Pharmaceuticals ACAD	708 M	$ 20.11	0.8 %	$ 3.39 B	USA
Achieve Life Sciences ACHV	16.5 M	$ 7.01	0.13 %	$ 306 M	USA
AC Immune SA ACIU	72.9 M	$ 2.71	0.55 %	$ 273 M	Schweiz
Aclaris Therapeutics ACRS	92.7 M	$ 4.27	0.79 %	$ 523 M	USA
ADC Therapeutics SA ADCT	334 M	$ 1.23	8.85 %	$ 156 M	Schweiz
Adial Pharmaceuticals ADIL	7.8 M	$ 4.35	5.58 %	$ 2.91 M	USA
ADMA Biologics ADMA	101 M	$ 10.11	4.01 %	$ 2.41 B	USA
Adaptive Biotechnologies Corporation ADPT	141 M	$ 29.84	5.26 %	$ 4.53 B	USA
Agenus AGEN	46 M	$ 8.73	4.43 %	$ 260 M	USA
AIM ImmunoTech AIM	14.4 M	$ 0.19	5.56 %	$ 308 K	USA
Akebia Therapeutics AKBA	173 M	$ 0.91	5.26 %	$ 234 M	USA
Akari Therapeutics, Plc AKTX	17.3 M	$ 8.76	0.46 %	$ 590 B	Britain
Aldeyra Therapeutics ALDX	34.7 M	$ 0.92	4.88 %	$ 55.3 M	USA
Alector ALEC	177 M	$ 1.99	9.94 %	$ 205 M	USA
Aligos Therapeutics ALGS	90.2 M	$ 5.4	0.36 %	$ 53.4 M	USA
Alkermes plc ALKS	640 M	$ 42.76	2.42 %	$ 7.04 B	Irlanda
Allogene Therapeutics ALLO	209 M	$ 1.5	0.33 %	$ 331 M	USA
Alnylam Pharmaceuticals ALNY	1.13 B	$ 219.89	0.08 %	$ 28.8 B	USA
Altimmune ALT	94.5 M	$ 2.67	0.36 %	$ 235 M	USA
ALX Oncology Holdings ALXO	104 M	$ 1.21	1.23 %	$ 64.9 M	USA